Molecular therapy for tuberculosis: AS-2, a derivative of 8-Hydroxyquinoline (8HQ), deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance, via upregulation of its target gene, 28/March/2019, 6.51 am